Examples that have already been reported include a mutation in a RET enhancer that increases Hirschsprung disease risk [87,88] as well as mutations that affect thalassemia, hemophilia, hypercholesterolemia, and pyruvate kinase deficiency [89]. Here, RET is linked to hemophilia.